5.155
4.71%
-0.255
시간 외 거래:
5.30
0.145
+2.81%
Outlook Therapeutics Inc (OTLK) 재무 분석
손익 계산서
분기별
*모든 숫자는 백만 단위입니다.
기간 종료일 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
기간 | 3개월 | 3개월 | 3개월 | 3개월 | 3개월 |
Revenues |
1,735%
-3.084
|
0.1887 | 0.3058 | 0.3952 | 0.1878 |
Operating Expenses
|
80.18%
18.94
|
10.51 | 12.76 | 18.54 | 7.0257 |
Benefits Costs and Expenses |
111.20
|
- | 13.30 | 21.07 | 6.8393 |
Costs And Expenses |
957.88%
111.20
|
10.51 | 13.30 | 21.07 | 6.8393 |
Provision For Loan, Lease, And Other Losses |
-
|
- | - | - | - |
Depreciation and Amortization |
0.00%
0.0282
|
0.0282 | 0.0112 | 0.0112 | 0.011 |
Operating Income/Loss |
83.47%
-18.94
|
-10.32 | -12.46 | -18.14 | -6.8379 |
Net Interest Income/Expense |
1,735%
-3.084
|
0.1887 | 0.3058 | 0.3952 | 0.1878 |
Interest Income/Expense After Provision For Losses |
1,735%
-3.084
|
0.1887 | 0.3058 | 0.3952 | 0.1878 |
Income/Loss Before Equity Method Investments |
61,485%
-114.26
|
0.1861 | -12.98 | -20.67 | -6.6345 |
Income/Loss From Equity Method Investments |
1,301%
-0.0306
|
0.00255 | -0.00835 | -0.00719 | -0.017 |
Income/Loss From Continuing Operations Before Tax |
922.40%
-114.29
|
-11.18 | -12.99 | -20.68 | -6.6515 |
Income Tax Expense/Benefit |
0.0028
|
- | - | - | 0.0028 |
Income/Loss From Continuing Operations After Tax |
922.42%
-114.29
|
-11.18 | -12.99 | -20.68 | -6.6543 |
Net Income/Loss
|
922.42%
-114.29
|
-11.18 | -12.99 | -20.68 | -6.6543 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
94.52%
14.27
|
260.26 | 3.2974 | 256.88 | 256.67 |
Diluted Average Shares |
94.52%
14.27
|
260.26 | 3.2974 | 256.88 | 256.67 |
Basic Earnings Per Share |
19,925%
-8.01
|
-0.04 | -0.05 | -0.08 | -0.03 |
Diluted Earnings Per Share |
19,925%
-8.01
|
-0.04 | -0.05 | -0.08 | -0.03 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
자본화:
|
볼륨(24시간):